155 related articles for article (PubMed ID: 15249178)
1. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection.
Bogoyevitch MA
Cardiovasc Res; 2004 Aug; 63(2):208-16. PubMed ID: 15249178
[TBL] [Abstract][Full Text] [Related]
2. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion.
Tada H; Kagaya Y; Takeda M; Ohta J; Asaumi Y; Satoh K; Ito K; Karibe A; Shirato K; Minegishi N; Shimokawa H
Cardiovasc Res; 2006 Aug; 71(3):466-77. PubMed ID: 16781691
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase.
Burger D; Lei M; Geoghegan-Morphet N; Lu X; Xenocostas A; Feng Q
Cardiovasc Res; 2006 Oct; 72(1):51-9. PubMed ID: 16904088
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase.
Burger DE; Xiang FL; Hammoud L; Jones DL; Feng Q
J Pharmacol Exp Ther; 2009 Jun; 329(3):900-7. PubMed ID: 19307451
[TBL] [Abstract][Full Text] [Related]
5. [Pleiotropic effects of erythropoietin].
Kes P; Basić-Jukić N; Furić-Cunko V
Acta Med Croatica; 2009 Sep; 63 Suppl 1():46-53. PubMed ID: 20232551
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1.
Rui T; Feng Q; Lei M; Peng T; Zhang J; Xu M; Abel ED; Xenocostas A; Kvietys PR
Cardiovasc Res; 2005 Feb; 65(3):719-27. PubMed ID: 15664399
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
Lipsic E; Schoemaker RG; van der Meer P; Voors AA; van Veldhuisen DJ; van Gilst WH
J Am Coll Cardiol; 2006 Dec; 48(11):2161-7. PubMed ID: 17161240
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin: ready for prime-time cardioprotection.
Riksen NP; Hausenloy DJ; Yellon DM
Trends Pharmacol Sci; 2008 May; 29(5):258-67. PubMed ID: 18359096
[TBL] [Abstract][Full Text] [Related]
9. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
[TBL] [Abstract][Full Text] [Related]
10. Activated STAT-1 pathway in the myocardium as a novel therapeutic target in ischaemia/reperfusion injury.
Stephanou A
Eur Cytokine Netw; 2002; 13(4):401-3. PubMed ID: 12517719
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-alpha.
Madonna R; Shelat H; Xue Q; Willerson JT; De Caterina R; Geng YJ
Exp Cell Res; 2009 Oct; 315(17):2921-8. PubMed ID: 19631208
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro.
Liu R; Suzuki A; Guo Z; Mizuno Y; Urabe T
J Neurochem; 2006 Feb; 96(4):1101-10. PubMed ID: 16417583
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.
Khan S; Salloum F; Das A; Xi L; Vetrovec GW; Kukreja RC
J Mol Cell Cardiol; 2006 Aug; 41(2):256-64. PubMed ID: 16769083
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
[TBL] [Abstract][Full Text] [Related]
15. Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
Jelkmann W; Wagner K
Ann Hematol; 2004 Nov; 83(11):673-86. PubMed ID: 15322761
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts.
Csete M; Rodriguez L; Wilcox M; Chadalavada S
Neurosci Lett; 2004 Apr; 359(1-2):124-6. PubMed ID: 15050726
[TBL] [Abstract][Full Text] [Related]
17. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.
Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Li L; Higuchi M; Minatoguchi S; Fujiwara T; Fujiwara H
Cardiovasc Res; 2006 Sep; 71(4):684-94. PubMed ID: 16828072
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.
Calvillo L; Latini R; Kajstura J; Leri A; Anversa P; Ghezzi P; Salio M; Cerami A; Brines M
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4802-6. PubMed ID: 12663857
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin and the heart: physiological effects and the therapeutic perspective.
Sanchis-Gomar F; Garcia-Gimenez JL; Pareja-Galeano H; Romagnoli M; Perez-Quilis C; Lippi G
Int J Cardiol; 2014 Feb; 171(2):116-25. PubMed ID: 24377712
[TBL] [Abstract][Full Text] [Related]
20. Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats.
Kiss K; Csonka C; Pálóczi J; Pipis J; Görbe A; Kocsis GF; Murlasits Z; Sárközy M; Szűcs G; Holmes CP; Pan Y; Bhandari A; Csont T; Shamloo M; Woodburn KW; Ferdinandy P; Bencsik P
Pharmacol Res; 2016 Nov; 113(Pt A):62-70. PubMed ID: 27521836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
